Evidence map›Paper›PMID 28137893›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

STAT3 Activation Impairs the Stability of Th9 Cells.

Benjamin J Ulrich, Felipe Fortino Verdan, Andrew N J McKenzie, Mark H Kaplan, Matthew R Olson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Expression Efficiency of MultipleImmunoHorizons · 2020
    Article
  11. Article
  12. BATF-Interacting Proteins Dictate Specificity in Th Subset Activity.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  13. Review
  14. Fas signaling-mediated TNature communications · 2019
    Article
  15. The Common Cytokine Receptor γ Chain Family of Cytokines.Cold Spring Harbor perspectives in biology · 2018
    Review
  16. Article
  17. Review
  18. The γF1000Research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Benjamin J UlrichDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0002-2729-1798
Felipe Fortino VerdanDepartment of Biochemistry and Immunology, University of São Paulo, Ribeirão Preto, 14049-900 São Paulo, Brazil; and.
Andrew N J McKenzieMedical Research Council Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge CB2 0QH, United Kingdom.
Mark H KaplanDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; mkaplan2@iupui.edu olsonmr@iupui.edu.ORCID 0000-0002-2923-8245
Matthew R OlsonDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; mkaplan2@iupui.edu olsonmr@iupui.edu.
Indiana University – Purdue University Indianapolis · USMRC Laboratory of Molecular Biology · GBUniversidade de São Paulo · BR

Funding

The role of PU.1 in T helper cell heterogeneityR01AI057459 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPLAN, MARK H · 2005 to 2025
$8.2M
Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
The Indiana Cutaneous Biological Research Training ProgramT32AR062495 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDROPHY, ELLIOT J. · 2013 to 2017
$649k
STAT3 in T helper cell developmentR03AI101628 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2013
$156k
Medical Research Council MC_U105178805NIAID NIH HHS R01 AI057459NIAID NIH HHS R03 AI101628NIAID NIH HHS T32 AI060519NIAMS NIH HHS T32 AR062495NIGMS NIH HHS T32 GM077229Wellcome Trust 100963
6 · The paper itself

Abstract

Th9 cells regulate multiple immune responses, including immunity to pathogens and tumors, allergic inflammation, and autoimmunity. Despite ongoing research into Th9 development and function, little is known about the stability of the Th9 phenotype. In this study, we demonstrate that IL-9 production is progressively lost in Th9 cultures during several rounds of differentiation. The loss of IL-9 is not due to an outgrowth of cells that do not secrete IL-9, as purified IL-9 secretors demonstrate the same loss of IL-9 in subsequent rounds of differentiation. The loss of IL-9 production correlates with increases in phospho-STAT3 levels within the cell, as well as the production of IL-10. STAT3-deficient Th9 cells have increased IL-9 production that is maintained for longer in culture than IL-9 in control cultures. IL-10 is responsible for STAT3 activation during the first round of differentiation, and it contributes to instability in subsequent rounds of culture. Taken together, our results indicate that environmental cues dictate the instability of the Th9 phenotype, and they suggest approaches to enhance Th9 activity in beneficial immune responses.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell DifferentiationCells, CulturedCell SurvivalGene Expression RegulationInflammationInterleukin-10Interleukin-9MiceMice, Inbred C57BLMice, KnockoutPhosphorylationSignal TransductionSTAT3 Transcription FactorInterleukin-10Interleukin-9Stat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID28137893
PMCPMC5340611
OpenAlexW2584036932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.